NUVECTIS PHARMA INC
NVCT·67080T108·US·Common Stock·Healthcare - Biotechnology-13D/G
NVCT (NUVECTIS PHARMA INC) is held by 51 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($18.4M), VANGUARD CAPITAL MANAGEMENT LLC ($16M), GEODE CAPITAL MANAGEMENT, LLC ($8M). Net institutional sentiment: Bullish.
51
Holders
(3 Elite)
$76.2M
Total Value
82% (51)
Consensus
42 buying - 9 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Jun 12, 2026 · Activists Aug 6, 2026 · Congress none
ActivistSOSoleus Capital Management, L.P.5.1%Aug 6, 2026
InsiderSJSanchez JuanVest 35K shJun 11, 2026
InsiderHKHoberman KennethVest 35K shJun 11, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 54
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer